Genetic test results can be hard to understand and interpret for people without a background in genetics. Investigators at Baylor College of Medicine’s Human Genome Sequencing Center are studying ...

New Orleans-based Ochsner Health was met with some uncertainty when it launched its pharmacogenomic program in March 2022 and became one of the first health systems to standardize genomic testing.

Enable more effective and targeted treatments that address unique needs for patients with pharmacogenomics. The traditional one-size-fits-all approach to medication has long been recognized as a ...

Pharmacogenomic testing for antidepressants could help reduce the time and cost it takes to find the most effective medication for a patient, according to a new study. Scientists developed a ...

Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...

A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient ...

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...

Pharmacogenomic testing, a mature and growing aspect of personalized medicine, has demonstrated significant ability to enhance health outcomes and reduce healthcare costs. Since the 1970s, ...

Rosalind Brown had blood clots in her lungs. For years, her doctors tried to get the dose of a blood thinner just right to prevent the risk of a heart attack or other life-threatening complications ...